Williams Gerald R, Iannotti Joseph P
Department of Orthopaedic Surgery, Thomas Jefferson University, and Rothman Institute at Jefferson, Philadelphia, PA 19107, USA.
J Shoulder Elbow Surg. 2007 Sep-Oct;16(5 Suppl):S267-72. doi: 10.1016/j.jse.2007.05.003.
Management of glenoid bone loss in shoulder arthroplasty is challenging. Currently available prosthetic, biologic, and composite prosthetic and biologic solutions are not ideal. The most common solutions involve a combination of asymmetric reaming, bone grafting, and standard polyethylene components. The development of additional prosthetic and biologic solutions may require a change in the way glenoid bone loss and component fixation are conceptualized. Classifications should be modified to consider the portions of the glenoid still remaining for fixation. In addition, the concept of placing glenoid components in the glenoid vault rather than on the subchondral surface, which is often deficient, should be developed. These changes may result in mass-produced glenoid components that could make management of glenoid bone loss more reproducible.
肩关节置换术中肩胛盂骨缺损的处理具有挑战性。目前可用的假体、生物和复合假体及生物解决方案并不理想。最常见的解决方案包括不对称扩孔、骨移植和标准聚乙烯组件的组合。开发更多的假体和生物解决方案可能需要改变肩胛盂骨缺损和组件固定的概念化方式。应修改分类方法,以考虑仍可用于固定的肩胛盂部分。此外,应提出将肩胛盂组件放置在肩胛盂穹顶而非通常有缺陷的软骨下表面的概念。这些改变可能会产生大规模生产的肩胛盂组件,使肩胛盂骨缺损的处理更具可重复性。